In this issue:
Impact of post-transplantation cyclophosphamide
PTCy-haplo donor age on posttransplantation outcomes
Primary-CHARM model
Reducing the dosage of PTCy
ATG versus ATLG
Sarcopenia on survival and posttransplant outcomes
Optimal salvage regimen before allo-HSCT
Outcomes and prognostic factors of allo-SCT
Please login below to download this issue (PDF)